ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 29 filers reported holding ALLIQUA BIOMEDICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,000 | -33.3% | 5,439 | -19.7% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 6,776 | +153.4% | 0.00% | – |
| Q1 2017 | $2,000 | -87.5% | 2,674 | -90.1% | 0.00% | – |
| Q4 2016 | $16,000 | +77.8% | 26,890 | +125.6% | 0.00% | – |
| Q3 2016 | $9,000 | -71.9% | 11,918 | -57.9% | 0.00% | – |
| Q2 2016 | $32,000 | +39.1% | 28,341 | +2.3% | 0.00% | – |
| Q1 2016 | $23,000 | -77.7% | 27,712 | -42.6% | 0.00% | – |
| Q4 2015 | $103,000 | -64.7% | 48,273 | -47.7% | 0.00% | – |
| Q3 2015 | $292,000 | -39.3% | 92,244 | +1.1% | 0.00% | – |
| Q2 2015 | $481,000 | +20.2% | 91,237 | +18.6% | 0.00% | – |
| Q1 2015 | $400,000 | +257.1% | 76,925 | +263.7% | 0.00% | – |
| Q4 2014 | $112,000 | +409.1% | 21,151 | +362.6% | 0.00% | – |
| Q3 2014 | $22,000 | +29.4% | 4,572 | +52.4% | 0.00% | – |
| Q2 2014 | $17,000 | -66.0% | 3,000 | -49.8% | 0.00% | – |
| Q1 2014 | $50,000 | – | 5,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 784,594 | $6,472,000 | 0.68% |
| J. Goldman & Co LP | 510,000 | $4,299,000 | 0.32% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 186,287 | $1,570,000 | 0.20% |
| JHL Capital Group LLC | 80,000 | $674,000 | 0.05% |
| Edge Wealth Management LLC | 4,930 | $42,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 5,000 | $42,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 100,000 | $843,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,671 | $14,000 | 0.00% |
| Family Capital Trust Co | 200 | $2,000 | 0.00% |
| MORGAN STANLEY | 5,979 | $50,000 | 0.00% |